UK markets open in 4 hours 42 minutes

GlaxoSmithKline plc (GSK.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
1,740.00-34.50 (-1.94%)
At close: 06:44PM BST
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in GBP. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
4,484,000
4,928,000
14,956,000
4,385,000
5,749,000
-
Depreciation & amortisation
2,203,000
2,294,000
2,147,000
2,122,000
2,050,000
-
Stock-based compensation
-
307,000
346,000
343,000
337,000
-
Change in working capital
165,000
-364,000
270,000
1,387,000
2,192,000
-
Inventory
-
-424,000
-269,000
51,000
100,000
-
Other working capital
5,295,000
4,424,000
5,145,000
5,298,000
6,496,000
-
Other non-cash items
430,000
470,000
350,000
602,000
1,202,000
-
Net cash provided by operating activities
7,673,000
6,768,000
7,403,000
7,952,000
8,441,000
-
Cash flows from investing activities
Investments in property, plant and equipment
-2,378,000
-2,344,000
-2,258,000
-2,654,000
-1,945,000
-
Acquisitions, net
-2,271,000
-1,591,000
-3,374,000
-294,000
-535,000
-
Purchases of investments
-
-
-
-
-1,000
-258,000
Sales/maturities of investments
-
72,000
1,000
18,000
3,269,000
-
Other investing activities
-
-
-3,791,000
-122,000
806,000
-
Net cash used for investing activities
-1,336,000
-1,595,000
-8,772,000
-1,777,000
2,161,000
-
Net change in cash
-46,000
-468,000
-546,000
-1,414,000
470,000
-
Cash at beginning of period
2,721,000
3,425,000
3,819,000
5,262,000
4,831,000
-
Cash at end of period
2,675,000
2,858,000
3,425,000
3,819,000
5,262,000
-
Free cash flow
Operating cash flow
7,673,000
6,768,000
7,403,000
7,952,000
8,441,000
-
Capital expenditure
-2,378,000
-2,344,000
-2,258,000
-2,654,000
-1,945,000
-
Free cash flow
5,295,000
4,424,000
5,145,000
5,298,000
6,496,000
-